Patents by Inventor Daphne A. Salick

Daphne A. Salick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Affinity peptides toward BMP-2
    Patent number: 8629106
    Abstract: We have disclosed affinity peptides toward BMP-2. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for BMP-2.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: January 14, 2014
    Assignee: Janssen Biotech, Inc.
    Inventors: John Kehoe, Daphne A. Salick, Carrie H. Fang, Chunlin Yang, Abla Creasey
  • Injectable ?-hairpin peptide hydrogel that kills methicillin-resistant
    Patent number: 8426559
    Abstract: A peptide comprising the sequence VKVKVRVKVDPPTKVKVRVKV-NH2 forms a hydrogel which has the ability to shear-thin and recover. The hydrogel, both before and after shear-thinning, is capable of killing bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).
    Type: Grant
    Filed: March 24, 2010
    Date of Patent: April 23, 2013
    Assignee: University of Delaware
    Inventors: Daphne A. Salick, Darrin J. Pochan, Joel P. Schneider
  • AFFINITY PEPTIDES TOWARD BMP-2
    Publication number: 20110230406
    Abstract: We have disclosed affinity peptides toward BMP-2. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for BMP-2.
    Type: Application
    Filed: March 10, 2011
    Publication date: September 22, 2011
    Applicant: Advanced Technologies and Regenerative Medicine, LLC
    Inventors: John Kehoe, Daphne A. Salick, Carrie H. Fang, Chunlin Yang, Abla Creasey
  • INJECTABLE BETA-HAIRPIN PEPTIDE HYDROGEL THAT KILLS METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
    Publication number: 20110171304
    Abstract: A peptide comprising the sequence VKVKVRVKVDPPTKVKVRVKV-NH2 forms a hydrogel which has the ability to shear-thin and recover. The hydrogel, both before and after shear-thinning, is capable of killing bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).
    Type: Application
    Filed: March 24, 2010
    Publication date: July 14, 2011
    Applicant: University of Delaware
    Inventors: Daphne A. Salick, Darrin J. Pochan, Joel P. Schneider